Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats

Bone marrow-derived mononuclear cells (BM-MNCs) were shown to improve the outcome in animal stroke models and clinical pilot studies on BM-MNCs for stroke patients were already conducted. However, relevant aspects of pre-clinical evaluation, such as the use of animals with comorbidities and dose-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnerup, Jens, Wagner, Daniel-Christoph, Strecker, Jan-Kolja, Pösel, Claudia, Sevimli-Abdis, Sevgi, Schmidt, Antje, Schilling, Matthias, Boltze, Johannes, Diederich, Kai, Schäbitz, Wolf-Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884213/
https://www.ncbi.nlm.nih.gov/pubmed/24409120
http://dx.doi.org/10.3389/fncel.2013.00288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884213/
https://www.ncbi.nlm.nih.gov/pubmed/24409120
http://dx.doi.org/10.3389/fncel.2013.00288

Ejemplares similares